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Abstract— Liver steatosis is a common disease usually as-
sociated with social and genetic factors. Early detection and
quantification is important since it can evolve to cirrhosis.
Steatosis is usually a diffuse liver disease, since it is globally
affected. However, steatosis can also be focal affecting only some
foci difficult to discriminate. In both cases, steatosis is detected
by laboratorial analysis and visual inspection of ultrasound
images of the hepatic parenchyma. Liver biopsy is the most
accurate diagnostic method but its invasive nature suggest the
use of other non-invasive methods, while visual inspection of
the ultrasound images is subjective and prone to error.
In this paper a new Computer Aided Diagnosis (CAD) system
for steatosis classification and analysis is presented, where the
Bayes Factor, obatined from objective intensity and textural
features extracted from US images of the liver, is computed in
a local or global basis. The main goal is to provide the physician
with an application to make it faster and accurate the diagnosis
and quantification of steatosis, namely in a screening approach.
The results showed an overall accuracy of 93.54% with a
sensibility of 95.83% and 85.71% for normal and steatosis class,
respectively. The proposed CAD system seemed suitable as a
graphical display for steatosis classification and comparison
with some of the most recent works in the literature is also
presented.
I. INTRODUCTION
Fatty liver infiltration, called steatosis, occurs when the
fat content of the hepatocytes increases [1]. Worldwide, the
prevalence of hepatic steatosis has increased, in great part
associated with obesity, insulin resistance and alcohol [2].
Early detection is of major clinical importance, since
steatosis is the first biomarker for the potential development
of cirrhosis and even hepatocellular carcinoma [2].
Liver biopsy remains the reference exam for the evaluation
of hepatic steatosis [2]. The need for biopsy reduction, due
to its invasive nature and the potential of sampling errors, has
led to the development of non-invasive methods for steatosis
diagnosis.
Among the new techniques for liver steatosis assessment,
imaging methods are widely reported in the literature. The
systematic review study of [2] shows that magnetic resonance
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imaging (MRI) performs better than ultrasound (US) and
computed tomography (CT). Nevertheless, drawbacks such
as exam cost and ionizing nature are shown in MRI and CT,
respectively. On the contrary, US shows a non-invasive, low
price, accessible, and non-ionizing nature.
The accumulation of fat in the liver leads to an increase of
brightness and changes on the textural characteristics of the
US images of the liver parenchyma. However, the source of
these changes may be in reflective echoes arising from other
hepatic diseases.
A large spectrum of studies has debated the optimal
and sub-optimal features extracted from US images for
steatosis classification purposes. In this scope, a set of
features extracted from the US liver parenchyma images are
used to detect the steatosis condition. The most common
features described in the literature are based on the first order
statistics [3], [4], co-occurrence matrix [5], wavelet transform
[6], [5], attenuation along the depth [7] and backscattering
[7] parameters and coefficients. Also, in this study, it is
compared the results of four different classifiers: Bayes, k-
nearest neighbor (kNN), Support Vector Machines (SVM):
polynomial and radial-basis kernels.
The development of the CAD system is here presented
based on the feature extraction/selection and classification
from US images. For this reason an improvement in the
usual US examination is attempted in this study. Moreover,
this CAD system is organized has a graphical interface, in
which the classification result is embedded in the original US
image, allowing a local fat analysis of the liver parenchyma.
This paper is organized as follows. Section II formulates
the problem, describes the image acquisition procedures, the
extraction and selection of features and the classifiers used.
Section III describes the experimental tests and presents the
classification results. It is also discussed the results from the
proposed CAD interface system. Section IV concludes the
paper.
II. MATERIALS AND METHODS
In a US pattern recognition problem, it is necessary to as-
sure the objectivity and reproducibility of image acquisition
before feature extraction and classification.
In this sense, an ultrasound machine preset was established
by using a fundamental frequency of 3.5 MHz, image depth
of 18 cm, two focal zones were set at the central portion
of the image (9 cm) and the dynamic range set in 75 dB.
Gain was variable, according to the patient biotype, and
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the depth gain compensation was set to its central position
and kept constant throughout the examinations. US images
were acquired only from the right liver lobe and the same
anatomical landmarks were used, in order to standardize the
acquisition protocol.
Images were stored in the Digital Imaging and Communi-
cations in Medicine (DICOM) format. From each US image,
a region-of-interest (ROI) of approximately 100×100 pixels
along the medial axis was extracted, using as criteria: i)
ROI sample should be visually representative of the liver
parenchyma; ii) major blood vessels and liver ligaments
should be avoid; and iii) the sample should be as superficial
as possible, to avoid US beam distortions.
Two important US features are used in clinical practice:
liver parenchyma echogenicity and its texture. According to
the studies [7], [8], [6], [5], [9], [10], the following features
were extracted. From the echogenicity point of view, the
acoustic attenuation coefficient is studied by means of the
slope of the linear regression of the mean image intensity
along the depth direction (lines).
In this work the attenuation coefficient, m, is estimated by
using the method proposed in [7]. This is addressed as the
following linear regression problem
mˆ = argmin
m
J (X), (1)
where X is the N × M US liver image. The objective
function is
J =
N∑
l=0
(αl + b− f(l))2, (2)
where f(l) = 1
M
∑M
c=1 xl,c is the average value intensity
of each image line, in the assumption, that depth increases
along each column.
From the textural point of view, two main features cat-
egories were extracted: I) using the wavelet transform, the
vertical, horizontal and diagonal detail components are ex-
tracted, of the first and second Haar wavelet decomposition
[11], and from it the energy and mean are computed; II) the
autoregressive (AR) model coefficients, θ = {a1,1, a1,0, a0,1},
corresponding to the coefficients of the first order 2D AR
model describing the image texture .
In the canonical definition of a 1D p-order AR model each
sample is modeled as a linear combination of the previous p
samples with unknown coefficients, ak [12]
x(l) =
p∑
i=1
aix(l − i) + r(l) (3)
where the residue signal, r(l), is assumed to be white and
zero mean normal distributed noise. For image applications
the following 2D formulation of the (p, q)-order AR model
is used [13]
x(l, c) =
p∑
i=0
q∑
j=0
aijx(c− i, l− j) + r(l, c) (4)
where x(l, c) is the l,cth pixel of the image and a0,0 = 0.
The first order model was adopted, as confirmed by [14].
A total of 36 features are extracted from the ROI US image
and wavelet decomposition components, for each patient.
For comparison purposes, we also extracted the features
suggested by [8], namely the median, standard deviation and
inter-quartile range extracted from each coefficient from the
2 levels of the wavelet packet transform using the Daubechies
3 wavelet and the original ROI.
Four types of classifiers, kNN, Bayes and SVM (polyno-
mial and radial-basis kernel) [15], are tested with three dif-
ferent sub-set of features: i) wavelet-based features proposed
by [8]; ii) using only the acoustic attenuation coefficient, as
used in [9], [10]; and iii) the set of features proposed in this
study, selected by the sequential forward floating selection
method [16].
Different parameterizations were tested: for the kNN, we
tested from k = 1, ..., 9 neighborhood configurations; for the
SVM polynomial kernel the cost (c) ranging from 1,10,50,
100, 150 and degree (d), d = 1, ..., 10; and for SVM with
radial-basis kernel the c parameter with the same range and
the radius (r) from r = 0.2, ..., 10 with steps of 0.2. Only
the best results are shown in this paper.
The classifiers result, according to the three sub-set of
features, are analyzed by means of the overall accuracy (OA),
sensibility (Se) and specificity (Sp) , in a leave-one-out cross-
validation basis. OA is weighted by class frequencies.
After the selection of the best feature set / classifier com-
bination, the Bayes factor is used to quantify the confidence
level of the classification, healthy or steatotic, in a global
and local basis. The Bayes factor is defined as follows,
Λ =
gF (x)
gN (x)
(5)
A confidence map image, S = {Λ(i, j)}, is computed
where each element is obtained from a small window cen-
tered at each (i, j)th pixel. This map aims at to detect foci fat
accumulation locations at the parenchyma and it is displayed
by using a color code image overlapped with the original US
image, diagnose map, D, according with the following law,
d(i, j) =
{
αΛ(i, j + (1− α)x(i, j) if s(i, j) > 0
x(i, j) otherwise
(6)
where x(i, j) is the original US image and Λ(i, j) is the
Bayes factor at the (i, j)th pixel. α is a weight parameter to
adjust the transparency.
III. EXPERIMENTAL RESULTS
Seventy-five (75) US liver images, obtained from 75
patients, were used in the classification process. Thirty-five
(35) patients had steatotic liver and 40 had normal liver. The
US images were acquired by expert operators in a Hospital
facility. The selected patients had known diagnosis based on
liver biopsy results. The study protocol was approved by the
Ethics Committee of the Hospital, it was explained to the
patients and an informed consent was obtained in each case.
As described three feature sets have been tested with
four different classifiers: A is the feature set proposed by
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TABLE I
BEST ACHIEVED DETECTION RATE (DR) AND OA FOR EACH TESTED
CLASSIFIER WITH THE THREE DIFFERENT FEATURE SET PROPOSED.
Feature Set Classifier ResultsNormal (%) Steatosis (%) OA (%)
A
Bayes 95.83 64.28 88.7
kNN 100 78.57 95.16
SVMpoly 93.75 71.42 88.7
SVMradial 87.5 78.57 85.7
B
Bayes 42.85 64.58 59.67
kNN 71.42 85.41 82.25
SVMpoly 93.75 50 83.87
SVMradial 87.5 78.57 85.7
C
Bayes 95.83 85.71 93.54
kNN 91.66 57.14 83.87
SVMpoly 85.41 71.42 82.25
SVMradial 87.5 57.14 80.64
[8], Feature set B correspond to the acoustic attenuation
coefficient, proposed originally by [7] and feature set C
that is the result of the feature selection procedure in which
we have incorporate the AR coefficients, extracted from the
wavelet detail decompositions.
From the original 36 extracted features only 6 were se-
lected, which formed feature set C. All features are computed
from the wavelet coefficients, from both levels, and are
mainly related with the AR coefficients, energy and pixel
mean, as shown in Figure 1. Individually, each feature shows
some overlapping between the considered classes.
Organized by the 3 feature sets, Table I resumes the
classification results. From feature set A, the best result was
achieved by using a kNN classifier (k=3), which revealed
an OA of 95.16%, with an optimal result for the normal
class, 100%, but with a low detection rate for the steatosis
class, 78.57%. In B the best results only attained 85.7% in
the OA with the SVM classifier, radial-basis kernel (r=1.2
and c=100). From this experience, the best achieved result
was observed for feature set C, with the Bayes classifier,
performing an OA of 93.54% with a detection rate of 95.83%
and 85.71% for normal and steatosis class, respectively.
In the study performed by [8], using a SVM classifier in
a leave-one-out cross validation approach, an OA of 95.6%
is achieved with sensitivity values for normal and steatosis
classes being 97.4% and 93.3%, respectively. Similar results
were also obtained by different studies [9], [7], [17]. The
present study is in accordance with this literature and similar
results were also obtained here. Based on these, enough
sensitivity is achieved to develop the graphical interface,
towards the CAD system.
We computed the Bayes factor, using the Bayes classifier
with feature set C, to form the diagnose map, D, displayed in
Figure 2. The Bayes factor and its graphical representation,
could be a helpful indicator for the quantification and local-
ization of the main foci of fat accumulation within the liver
parenchyma, in the sense that it allows a graphical correlation
between the classification results and their localization in the
original US image.
Figure 2 displays the algorithm results of US images
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Fig. 1. Estimated density distribution plots obtained for each of the selected
feature: (a) Energy of the wavelet horizontal detail coefficient, level 1; (b)
a1,0 and (c) a0,1 calculated from the horizontal detail coefficient, level 2;
(d) a0,1 from the diagonal detail coefficient, level 1; (e) mean and (f) a1,1
of the vertical detail coefficient, level 2.
from one healthy and steatotic liver sample, respectively.
The resultant map images, confidence and diagnose, show
that the yellow to red color regions indicate high probability
of fat presence, the green region indicates that there aren’t
enough evidence to support a decision and the light to
dark blue regions indicate normal liver tissue. These results
show that the physician can select an US ROI, within the
area corresponding to the liver parenchyma, and obtain a
confidence map image that illustrate the local classification
results, based on the Bayes factor. The diagnose map images
allow the physician to have an overall relationship between
the local classification results and the original US ROI, as
well as gives a notion of the spatial relationship of the
selected ROI with the rest of the anatomical structures.
IV. CONCLUSIONS
In this paper a new CAD system for steatosis analysis is
presented, developed from the US-based features, extracted
from the wavelet transform detail coefficients, by using a
Bayes classifier.
Among the four classifiers tested with three different sets
of features, the best result, in a leave-one-out basis, led to
an OA of 93.54% with a sensibility of 95.83% and 85.71%
for normal and steatosis class, respectively.
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Fig. 2. Classification results displayed in the developed CAD system
interface. From top to bottom, it is observed a steatotic sample with the
correct classification result (steatotic), a steatotic sample that, due to lack
of evidence to support the decision, it is not well classified and in the bottom
a normal US liver sample that is also correctly classified.
An important result from this preliminary study, was that
the AR coefficients, extracted from the multi-scale Haar
wavelet decomposition, are particular relevant for the classi-
fication of liver steatosis by US images.
Based on the results, global and local assessment of liver
tissue described by means of the Bayes factor can provide
useful information to the physician about the confidence of
the classification as well as the classification itself.
Further studies are needed, particularly, with higher num-
ber of patients, as well as with more correlation between
clinical features and US-based features. Another issue is that
in clinical practice it is important to discriminate between
different steatosis stages. For further studies, this topic will
be attempt by changing the classification and display schema
to handle multiple classes.
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